# Arcutis Biotherapeutics, Inc.: Form 8-K, filed Dec 8, 2025

- Company: [Arcutis Biotherapeutics, Inc.](/companies/arqt.md) (CIK 1787306)
- Form: 8-K
- Filed: 2025-12-08
- Accepted by EDGAR: Dec 8, 2025, 16:28 ET
- Period: 2025-12-03
- Accession: 0001787306-25-000147
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1787306/000178730625000147/arqt-20251203.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1787306/000178730625000147/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1787306/000178730625000147/arqt-20251203.htm

Filed Dec 8, 2025.
Source: SEC EDGAR, the filing index for accession 0001787306-25-000147. Last ingested by Listed: Oct 28, 2026, 09:04 ET. No prices; not investment advice.